155 related articles for article (PubMed ID: 37577341)
1. Gastric neuroendocrine carcinoma presenting complete durable response by nivolumab treatment for multiple metastases and radiotherapy to oligoprogressive metastasis.
Seyama Y; Yamada T; Suzuki H; Fukuda S; Tsuji M; Niisato Y; Hirose S; Yamamoto Y; Moriwaki T; Hyodo I
Int Cancer Conf J; 2023 Oct; 12(4):268-273. PubMed ID: 37577341
[TBL] [Abstract][Full Text] [Related]
2. Nivolumab exerts therapeutic effects against metastatic lesions from early gastric adenocarcinoma with a small proportion of neuroendocrine carcinoma after gastrectomy: a case report.
Sawayama H; Komohara Y; Hirao H; Sakata K; Takata N; Yoshinaka I; Harada K; Baba H
Clin J Gastroenterol; 2020 Oct; 13(5):759-765. PubMed ID: 32592148
[TBL] [Abstract][Full Text] [Related]
3. [Brain Metastasis Arising from Gastric Cancer during Long-Term Treatment Using Nivolumab].
Namikawa T; Marui A; Yokota K; Kawanishi Y; Munekage M; Uemura S; Maeda H; Kitagawa H; Nagata Y; Kobayashi M; Hanazaki K
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1544-1546. PubMed ID: 36733129
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab.
Namikawa T; Ishida N; Tsuda S; Fujisawa K; Munekage E; Iwabu J; Munekage M; Uemura S; Tsujii S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
Surg Case Rep; 2018 Jul; 4(1):71. PubMed ID: 29978335
[TBL] [Abstract][Full Text] [Related]
5. Nivolumab in combination with radiotherapy for metastatic esophageal neuroendocrine carcinoma after esophagectomy: a case report.
Takagi K; Kamada T; Fuse Y; Kai W; Takahashi J; Nakashima K; Nakaseko Y; Suzuki N; Yoshida M; Okada S; Ohdaira H; Suzuki Y
Surg Case Rep; 2021 Oct; 7(1):221. PubMed ID: 34596772
[TBL] [Abstract][Full Text] [Related]
6. Complete and Durable Response to Nivolumab in Recurrent Poorly Differentiated Pancreatic Neuroendocrine Carcinoma with High Tumor Mutational Burden.
Kang NW; Tan KT; Li CF; Kuo YH
Curr Oncol; 2021 Nov; 28(6):4587-4596. PubMed ID: 34898561
[TBL] [Abstract][Full Text] [Related]
7. Conversion surgery for gastric remnant cancer with liver metastasis after nivolumab combination chemotherapy achieving pathological complete response: a case report and literature review.
Katsumata K; Morimoto Y; Aoyama J; Yamada T; Katsuki Y; Nishiyama R; Egawa T
Surg Case Rep; 2024 May; 10(1):107. PubMed ID: 38691201
[TBL] [Abstract][Full Text] [Related]
8. Thymoquinone Plus Immunotherapy in Extra-Pulmonary Neuroendocrine Carcinoma: Case Series for a Novel Combination.
Mohamed A; Azmi AS; Asa SL; Tirumani SH; Mahipal A; Cjakrabarti S; Bajor D; Selfridge JE; Kaseb AO
Curr Oncol; 2022 Nov; 29(11):9018-9030. PubMed ID: 36421360
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Effective Disease Control of Advanced Gastric Cancer with Distant Lymph Node Metastases Following Nivolumab Treatment].
Nakamura N; Kinami S; Fujita J; Kaida D; Tomita Y; Miyata T; Fujita H; Takamura H; Ueda N; Kosaka T
Gan To Kagaku Ryoho; 2020 Aug; 47(8):1258-1260. PubMed ID: 32829368
[TBL] [Abstract][Full Text] [Related]
10. Gastric adenocarcinoma is concurrent with metastatic neuroendocrine cancer treated with nivolumab and chemotherapy: A case report.
Yan B; Cui M; You J; Li F; Liu H
Mol Clin Oncol; 2018 Dec; 9(6):607-612. PubMed ID: 30546888
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW
World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088
[TBL] [Abstract][Full Text] [Related]
12. [A Case of Lymph Nodes Metastases of Gastric Neuroendocrine Carcinoma Treated with Nivolumab and Showing Complete Response].
Wada N; Takachi K; Shirosaki Y; Fujiwara M; Fukuda N; Matsuura Y; Munakata K; Takiuchi D; Hama N; Ota H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1546-1547. PubMed ID: 38303336
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine carcinoma of the gastric stump: A case report and literature review.
Ma FH; Xue LY; Chen YT; Xie YB; Zhong YX; Xu Q; Tian YT
World J Gastroenterol; 2018 Jan; 24(4):543-548. PubMed ID: 29398875
[TBL] [Abstract][Full Text] [Related]
14. Complete Response to Nivolumab of Resected Adenocarcinoma NOS With Parotid Gland Origin and Lung Metastasis.
Negishi Y; Okamoto I; Ueda Y; Sato H; Tanigawa M; Nagao T; Tsukahara K
In Vivo; 2022; 36(6):2840-2843. PubMed ID: 36309400
[TBL] [Abstract][Full Text] [Related]
15. Durable complete remission with local therapies after neoadjuvant and adjuvant nivolumab in recurrent/metastatic head and neck cancer.
Cabezas-Camarero S; Iglesias-Moreno MC; Cerezo Druet E; Sotelo MJ; Merino-Menéndez S; Cabrera-Martín MN; Plaza-Hernández JC; Pérez-Segura P
Anticancer Drugs; 2023 Jun; 34(5):695-698. PubMed ID: 36730545
[TBL] [Abstract][Full Text] [Related]
16. A case of multiple metastatic gastric cancer with primary lesion vanished after administrating nivolumab, and the effect remains even after discontinuance of therapy.
Doi H; Ninomiya M; Toyota K; Hirahara S; Kuhara Y; Shirakawa K; Yano R; Kobayashi H; Hashimoto Y; Yokoyama Y; Sakashita Y; Miyamoto K
Int Cancer Conf J; 2020 Oct; 9(4):187-192. PubMed ID: 32904060
[TBL] [Abstract][Full Text] [Related]
17. Poorly Differentiated Neuroendocrine Carcinoma of Unknown Primary with Metastasis to the Testis: A Case Report.
Sano M; Noguchi M; Kinoshita A; Nakamura M; Koike K; Saruta M
Case Rep Oncol; 2022; 15(1):388-393. PubMed ID: 35702557
[TBL] [Abstract][Full Text] [Related]
18. Exploring Real World Outcomes with Nivolumab Plus Ipilimumab in Patients with Metastatic Extra-Pulmonary Neuroendocrine Carcinoma (EP-NEC).
Mohamed A; Vijayvergia N; Kurian M; Liu L; Fu P; Das S
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681675
[No Abstract] [Full Text] [Related]
19. Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network.
Hadoux J; Kanaan C; Durand A; Hescot S; Hautefeuille V; Cadiot G; Tauveron I; Laboureau S; Do Cao C; Walter T; Petorin C; Blanchet O; Jannin A; Gu C; Faron M; Leteurtre E; Rousselet MC; Zakeyh JJ; Marchal A; Chatelain D; Beaulaton C; Hervieu V; Ducreux M; Scoazec JY; Baudin E
Eur J Cancer; 2021 Jul; 152():100-115. PubMed ID: 34090142
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical consistency between primary tumors and lymph node metastases of gastric neuroendocrine carcinoma.
Uchiyama C; Tamura S; Nakatsuka S; Takeno A; Miki H; Kanemura T; Nakahira S; Suzuki R; Nakata K; Takeda Y; Kato T
World J Surg Oncol; 2012 Jun; 10():115. PubMed ID: 22726317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
